The center intends to facilitate partnerships, exchange knowledge and promote innovative regulatory approaches.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.
Drop the checkbox mentality and embrace accountability and understanding.
The total value of deals for 2019 exceeds $30 billion.
This new pathway is a considerable change for the medical device industry.